Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilio Santander

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitisPilar Navarro, Emilio J Laserna-Mendieta, Danila Guagnozzi, et al.
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Alimentary Pharmacology & Therapeutics|December 16, 2024
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic OesophagitisAlfredo J Lucendo, Óscar Nantes-Castillejo, Alex Straumann, et al.
Journal of Clinical Medicine|January 10, 2026
Artificial Intelligence and FLIP Panometry-Automated Classification of Esophageal Motility PatternsMiguel Mascarenhas, Francisco Mendes, João Rala Cordeiro, et al.
Nutrients|January 5, 2021
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease MonitoringEmilio J Laserna-Mendieta, María José Casanova, Ángel Arias, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2025
Digestive disease in individuals living with obesity: beyond weight lossJavier Crespo, Fernando Alberca, Marta Alonso-Peña, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Allergy|August 2, 2024
Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment responseFrancisca Molina-Jiménez, Lola Ugalde-Triviño, Laura Arias-González, et al.
International Journal of Molecular Sciences|November 14, 2023
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their ModulationMontse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitisPilar Navarro, Emilio J Laserna-Mendieta, Danila Guagnozzi, et al.
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Alimentary Pharmacology & Therapeutics|December 16, 2024
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic OesophagitisAlfredo J Lucendo, Óscar Nantes-Castillejo, Alex Straumann, et al.
Journal of Clinical Medicine|January 10, 2026
Artificial Intelligence and FLIP Panometry-Automated Classification of Esophageal Motility PatternsMiguel Mascarenhas, Francisco Mendes, João Rala Cordeiro, et al.
Nutrients|January 5, 2021
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease MonitoringEmilio J Laserna-Mendieta, María José Casanova, Ángel Arias, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2025
Digestive disease in individuals living with obesity: beyond weight lossJavier Crespo, Fernando Alberca, Marta Alonso-Peña, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Allergy|August 2, 2024
Proton pump inhibitor effect on esophageal protein signature of eosinophilic esophagitis, prediction, and evaluation of treatment responseFrancisca Molina-Jiménez, Lola Ugalde-Triviño, Laura Arias-González, et al.
International Journal of Molecular Sciences|November 14, 2023
Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their ModulationMontse Baldan-Martin, Cristina Rubín de Célix, Macarena Orejudo, et al.
Pageof 9